Potential Role of Rho-Associated Protein Kinase Inhibitors for Glaucoma Treatment

Publisher： Bentham Science Publishers

E-ISSN： 2212-3334|6|2|89-98

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.6, Iss.2, 2012-05, pp. : 89-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Isoform Selective Phosphoinositide 3-Kinase amp;#947; and amp;#948; Inhibitors and Their Therapeutic Potential

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 2, Iss. 1, 2008-01 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphoinositide 3-Kinase Gamma (PI3K&ggr;) Inhibitors for the Treatment of Inflammation and Autoimmune Disease

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 1, 2010-01 ,pp. : 1-15

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Phosphoinositol 3 Kinase and NF&kgr;B for the Treatment of Chronic Obstructive Pulmonary Disease

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 178-183

Bentham Science Publishers

Access to resources Recommend Favorite

The 2010 Patent Landscape for Spleen Tyrosine Kinase Inhibitors+

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 6, Iss. 2, 2012-01 ,pp. : 97-120

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Patents Concerning Modulators of Protein Kinase C

By  

Recent Patents on DNA & Gene Sequences, Vol. 7, Iss. 1, 2013-04 ,pp. : 74-81

Bentham Science Publishers

Access to resources Recommend Favorite